trichostatin-a and Hypesthesia

Hypoesthesia is a clinical feature of neuropathic pain. The feature is partly explained by the evidence of epigenetic repression of Nav 1.8 sodium channel in the dorsal root ganglion (DRG).. We investigated the possibility of trichostatin A (TSA), valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) to reverse the unique C-fibre sensitivity observed following partial ligation of sciatic nerve in mice.. Nerve injury-induced down-regulation of DRG Nav 1.8 sodium channel and C-fibre-related hypoesthesia were reversed by TSA, VPA and SAHA treatments, which inhibit histone deacetylase (HDAC), and increase histone acetylation at the regulatory sequence of Nav 1.8.. Taken together, these studies provide the evidence that hypoesthesia and underlying down-regulation of Nav 1.8, negative symptoms observed in nerve injury-induced neuropathic pain models are regulated by an epigenetic chromatin remodelling through HDAC-related machineries.

Topics: Acetylation; Analgesics; Animals; Chromatin Assembly and Disassembly; Disease Models, Animal; Epigenesis, Genetic; Ganglia, Spinal; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Hypesthesia; Ligation; Male; Mice; Mice, Inbred C57BL; NAV1.8 Voltage-Gated Sodium Channel; Nerve Fibers, Unmyelinated; Pain Measurement; Pain Threshold; Sciatic Nerve; Sciatic Neuropathy; Time Factors; Valproic Acid; Vorinostat